The U.S. Market for OTC Gastrointestinal Products

Attention: There is an updated edition available for this report.
 
   Single User - $2,437


Loading...
Published Jun 1, 2001 | 187 Pages | Pub ID: KLI326302

Special Offer: Now 25% off original sale price of $3250
The US Market for OTC Gastrointestinal Products is a comprehensive analysis of the impact OTC drugs have made to the gastrointestinal market. This study provides a detailed market size analysis for the years 1996 - 2000 and market forecasts to the year 2006. Within the OTC Gastrointestinal Product Market three market segments are covered, including: Antacids, H2 Receptor Antagonists, and Other Gastrointestinal Products. A thorough description of upper gastrointestinal conditions and diseases, treatments, and preventive care are included in this study. Trends covered in the report include dual regulatory status, consumer interests in self-medication, and impact of direct-to-consumer advertising. The US Market for OTC Gastrointestinal Products will provide the reader with a comprehensive analysis of gastrointestinal products currently marketed products potentially entering the market. The study focuses on the direction this market is taking and the contributing factors for continued growth. Detailed profiles of major competitors are provided.

Executive Summary


    Introduction
    Scope and Methodology
    Size and Growth of the Market
    Issues and Trends Affecting the OTC Market
    Leading Competitors

Introduction


    History and Growth of the OTC Market
    Industry Structure
    Food and Drug Administration
    Rx-to-OTC Switches
    Generics
    The Consumer
    Overview of the Upper Gastrointestinal System
    Description of Upper Gastrointestinal Diseases and Conditions
    Gastritis
    GERD (Gastro Esophageal Reflux Disease)
    Heartburn and Indigestion
    Peptic Ulcer Disease
    Prevalence, Incidence
    Risk Factors
    Cost

Antacids


    Overview
    Description of Products
    Aluminum Compounds
    Calcium Carbonates
    Magnesium Compounds
    Combination Preparations
    Rx-to-OTC Switches
    Generic Participation
    Market Size and Growth
    Competitive Analysis

H2 Receptor Antagonists


    Overview
    Description of Products
    Rx-to-Otc Switches
    Generic Participation
    Market Size and Growth
    Competitive Analysis

Other OTC Gastrointestinal Products


    Overview
    Description of Products
    Rx-to-OTC Switches
    Potential Rx-to-OTC Switches
    Generic Participation
    Market Size and Growth
    Potential Market
    Competitive Analysis

Issues And Trends Affecting The OTC Gastrointestinal Product Market


    Introduction
    Consumer Issues
    Education and Self-Medication
    Prescription vs. Over-the-Counter Cost
    Direct-to-Consumer Advertising
    Impact.
    Cost
    Distribution
    Dual Regulatory Status
    Generic Activity and Impact
    Insurance and Reimbursement Issues
    Legislative and Regulatory Issues
    Rx-to-OTC Switch Products
    OTC Labeling Issues
    Line Extensions
    International OTC Trends

Total Market Size And Forecast


    Overview
    Total market Size and Forecast
    Potential Products and Market Forecast
    Competitor Analysis
    Market Analysis

Company Profiles


    3M Company
    Bayer Corporation
    GlaxoSmithKline Consumer Healthcare
    Johnson & Johnson
    McNeil Consumer Healthcare
    Merck & Company, Inc
    Novartis Pharmaceuticals Corporation
    Perrigo Company
    Procter & Gamble Company
    Warner-Lambert Consumer Group/Pfizer
    Watson Pharmaceuticals, Inc.
    Whitehall-Robins Healthcare, Inc.
    Zenith Goldline Pharmaceuticals, Inc.
    Competitive Summary

Company Names And Addresses

List of Exhibits

Chapter One: Executive Summary


    Table 1-1: The U.S. Market for OTC Gastrointestinal Products, by Type, 1996, 2000, and 2006
    Table 1-2: The U.S. Market for OTC Gastrointestinal Products, by Type and Percent Distribution, 1996, 2000, and 2006
    Figure 1-1: The U.S. Market for OTC Gastrointestinal Products, by Type and Revenues, 1996, 2000, and 2006
    Figure 1-2: The U.S. Market for OTC Gastrointestinal Products, by Type and Percent Distribution, 2000
    Table 1-3: Leading Suppliers’ Shares of the U.S. Market for OTC Gastrointestinal Products, 2000
    Figure 1-3: Leading Suppliers’ Shares of the U.S. Market for OTC Gastrointestinal Products, 2000

Chapter Two: Introduction


    Table 2-1: Gastrointestinal Rx-to-OTC Switches by Supplier and Year, 1988-2000
    Table 2-2: Average U.S. Prescription Drug Expenditures per Capita, 1990-2000
    Figure 2-1: Average U.S. Prescription Drug Expenditures per Capita, 1990-2000
    Table 2-3: U.S. Population by Age and Sex, 1996-2006
    Figure 2-2: U.S. Population by Sex, 1996-2006
    Figure 2-3: U.S. Population by Age, 1996-2006
    Table 2-4: U.S. Life Expectancy by Sex, 1996-1999
    Figure 2-4: U.S. Life Expectancy by Sex, 1996-1999
    Table 2-5: U.S. Incidence of GERD Symptoms, 2000
    Figure 2-5: U.S. Incidence of GERD Symptoms, 2000
    Table 2-6: U.S. Incidence of Heartburn and Indigestion Symptoms, 2000
    Figure 2-6: U.S. Incidence of Heartburn and Indigestion Symptoms, 2000
    Table 2-7: U.S. Incidence of Heartburn and Indigestion in Pregnant Women, 2000
    Figure 2-7: U.S. Incidence of Heartburn in Pregnant Women, 2000
    Table 2-8: U.S. Incidence of Peptic Ulcer Disease, 2000
    Figure 2-8: U.S. Incidence of Peptic Ulcer Disease, 2000
    Table 2-9: Common Over-the-Counter Treatments for Ulcer Healing, by Dose and Duration
    Table 2-10: U.S. Annual Health Care Costs of Ulcers, 2000
    Table 2-11: U.S. Average Cost of Treating Ulcers by Treatment Type, 2000

Chapter Three: Antacids


    Table 3-1: Commonly Used Brand Name Aluminum Antacids by Active Ingredient and Manufacturer
    Table 3-2: Commonly Used Brand Name Calcium Antacids by Active Ingredient and Manufacturer
    Table 3-3: Commonly Used Brand Name Magnesium Antacids by Active Ingredient and Manufacturer
    Table 3-4: Commonly Used Brand Name Combination Antacids by Active Ingredient and Manufacturer
    Table 3-5: Generic Antacids by Manufacturer
    Table 3-6: The U.S. Market for OTC Antacids, 1996-2006
    Figure 3-1: The U.S. Market for OTC Antacids, 1996-2006
    Table 3-7: The U.S. Market for OTC Antacids by Percent and Type, 1996-2006
    Figure 3-2: The U.S. Market for OTC Antacids by Type and Revenues, 1996-2006
    Figure 3-3: The U.S. Market for OTC Antacids by Percent and Type 2000
    Table 3-8: U.S. Sales of Leading OTC Antacids, by Product and Supplier, 2000
    Figure 3-4: U.S. Sales of Leading OTC Antacids, by Product and Supplier, 2000
    Table 3-9: Leading Suppliers’ Shares of the U.S. Market for OTC Antacids, 2000
    Figure 3-5: Leading Suppliers’ Shares of the U.S. Market for OTC Antacids, 2000

Chapter Four: H2 Receptor Antagonists


    Table 4-1: Brand Name H2 Receptor Antagonists by Active Ingredient and Manufacturer
    Table 4-2: Generic H2 Receptor Antagonists by Manufacturer
    Table 4-3: The U.S. Market for OTC H2 Receptor Antagonists, 1996-2006.
    Figure 4-1: The U.S. Market for OTC H2 Receptor Antagonists, 1996-2006
    Table 4-4: The U.S. Market for OTC H2 Receptor Antagonists by Percent and Type, 1996-2006
    Figure 4-2: The U.S. Market for OTC H2 Receptor Antagonists by Type and Revenues, 1996-2006
    Figure 4-3: The U.S. Market for OTC H2 Receptor Antagonists by Percent and Type, 2000
    Table 4-5: U.S. Sales of Leading OTC H2 Receptor Antagonists, by Product and Supplier, 2000
    Figure 4-4: U.S. Sales of Leading OTC H2 Receptor Antagonists, by Product and Supplier, 2000
    Table 4-6: Leading Suppliers’ Shares of the U.S. Market for OTC H2 Receptor Antagonists, 2000
    Figure 4-5: Leading Suppliers’ Shares of the U.S. Market for OTC H2 Receptor Antagonists, 2000

Chapter Five: OTC Other Gastrointestinal Products


    Table 5-1: Brand Name OTC Other Gastrointestinal Products by Active Ingredient and Manufacturer
    Table 5-2: Generic OTC Other Gastrointestinal Products by Manufacturer
    Table 5-3: The U.S. Market for OTC Other Gastrointestinal Products, 1996-2006
    Figure 5-1: The U.S. Market for OTC Other Gastrointestinal Products, 1996-2006
    Table 5-4: The U.S. Potential Market for Other Gastrointestinal Products Based on Projected Switches, 2003-2006
    Figure 5-2: The U.S. Potential Market for Other Gastrointestinal Products Based on Projected Switches, 2003-2006
    Table 5-5: U.S. Sales of Leading OTC Other Gastrointestinal Products, by Product and Supplier, 2000
    Figure 5-3: U.S. Sales of Leading OTC Other Gastrointestinal Products, by Product and Supplier, 2000
    Table 5-6: Leading Suppliers’ Shares of the U.S. Market for OTC Other Gastrointestinal Products, 2000
    Figure 5-4: Leading Suppliers’ Shares of the U.S. Market for OTC Other Gastrointestinal Products, 2000

Chapter Six: Issues And Trends Affecting The OTC Gastrointestinal Product Market


    Table 6-1: Cost of OTC Direct-to-Consumer Advertising of Leading OTC Gastrointestinal Pharmaceuticals, 1995 and 1998
    Figure 6-1: Cost of OTC Direct-to-Consumer Advertising of Leading OTC Gastrointestinal Pharmaceuticals, 1995 and 1998
    Table 6-2: National Distribution of OTC Pharmaceuticals, by Selected Retail Stores and Wholesalers

Chapter Seven: Total Market Size And Forecast


    Table 7-1: The U.S. Market for OTC Gastrointestinal Products, by Type, 1996-2006
    Table 7-2: The U.S. Market for OTC Gastrointestinal Products, by Percent and Type, 1996-2006
    Figure 7-1: The U.S. Market for OTC Gastrointestinal Products, by Type and Revenues, 1996-2006
    Figure 7-2: The U.S. Market for OTC Gastrointestinal Products, by Percent and Type, 2000
    Table 7-3: The U.S. Potential Market for Gastrointestinal Products Based on Projected Switches, 2000-2006
    Figure 7-4: The U.S. Potential Market for Gastrointestinal Products Based on Projected Switches, 2003-2006
    Table 7-4: Top Five OTC Gastrointestinal Products, by Product Sales, 2000
    Figure 7-4: Top Five OTC Gastrointestinal Products, by Product Sales, 2000
    Table 7-5: Leading Suppliers’ Shares of the U.S. Market for OTC Gastrointestinal Products, 2000
    Figure 7-5: Leading Suppliers’ Shares of the U.S. Market for OTC Gastrointestinal Products, 2000

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.